333 related articles for article (PubMed ID: 32370480)
1. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
2. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
4. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
5. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.
Nakamura K; Toba T; Otake H; Kakizaki S; Fujimoto D; Takahashi Y; Fukuyama Y; Kawamori H; Tanaka H; Takaya T; Iwasaki M; Kozuki A; Kawai H; Hayashi T; Shite J; Hirata KI
Heart Vessels; 2022 Nov; 37(11):1937-1946. PubMed ID: 35641828
[TBL] [Abstract][Full Text] [Related]
6. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy.
Faber L; Welge D; Hering D; Butz T; Oldenburg O; Seggewiss H; Horstkotte D
Clin Res Cardiol; 2008 Dec; 97(12):899-904. PubMed ID: 18777001
[TBL] [Abstract][Full Text] [Related]
8. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ
Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
12. Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.
Batzner A; Pfeiffer B; Neugebauer A; Aicha D; Blank C; Seggewiss H
J Am Coll Cardiol; 2018 Dec; 72(24):3087-3094. PubMed ID: 30545446
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Risk Factors for Related Complications of Chemical Ablation on Hypertrophic Obstructive Cardiomyopathy.
Li CY; Shi YQ
Arq Bras Cardiol; 2019 Apr; 112(4):432-438. PubMed ID: 30942295
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
16. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
17. Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.
Meng X; Liang M; Shi Y; Zhang W; Zhou S; Gao C
Anatol J Cardiol; 2020 Jun; 23(6):342-348. PubMed ID: 32478684
[TBL] [Abstract][Full Text] [Related]
18. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]